Efficacy and Safety Study of Guanxin Shutong Capsule to Treat Chronic Stable Angina

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.

Also called NCT02280850

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
Shaanxi Buchang Pharmaceutical Co., Ltd (from the registry)
Registry
  • NCT NCT02280850
Other papers using this trial's data
  • Efficacy and safety of oral Guanxinshutong capsules in patients with stable angina pectoris in China: a prospective, multicenter, double-blind, placebo-controlled, randomized clinical trial BMC complementary and alternative medicine, 2019-12-11 DOI, PubMed 31829173, PMC6907120 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02280850. Randomized; quadruple masking; primary purpose treatment. Start 2014-10 (registry gives no type); primary completion 2015-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety Study of Guanxin Shutong Capsule to Treat Chronic Stable Angina
Condition
Angina, Stable
Intervention (Drug)
Guanxin Shutong Capsule
Intervention (Drug)
Placebo Capsule
Intervention (Drug)
nitroglycerine
Lead sponsor
Shaanxi Buchang Pharmaceutical Co., Ltd (class: industry)

Record details

Record id
cardio:ct-nct02280850
Content hash
24b24879eb96cf68094c6224bbd80b2bd6f7883d982f67ea19de97d64832abbb